# US 6,730,323 B1 · Microclysmic gel for treatment of tissue trauma and burns

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,323 B1
- Document ID: US6730323B1
- Status: Granted
- Kind: B1
- Application number: 08/769,596
- Filed: 1996-12-18
- Granted: 2004-05-04
- Earliest claimed: 1996-12-18
- Assignees: Care Teck Laboratories, Inc.
- Inventors: Jack C. Murley; John C. Brereton
- Web page: https://patentgrep.com/patent/US6730323B1

## CPC

- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 38/012: {from animals}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A therapeutic wound gel is provided which will enhance healing of the wound and reduce swelling and increase elasticity of the skin. Humatrix is bacteriostatic protectant with no bacteriocidal activity. The gel consist essentially of by weight percent, about 88-97% water, about 0.4-0.6% carbomer, about 1.2-7.8% propylene glycol, about 0.6-1.3% glycerin, about 0.5% DMDM Hydantoin, about 0-0.8% citric acid, about 0.1% chondroitin sulfate and animal protein, and about 0-0.6% triethanolamine. The gel is formed in three phases which are combined together, the first phase consisting essentially of about 88-99% of the water of the gel, the carbomer, the propylene glycol, and the glycerin; the second phase consisting essentially of the remaining water, the DMDM Hydantoin, and the citric acid if needed; and the third phase consisting essentially of the chondroitin sulfate and animal protein and the triethanolamine, if needed.

## Claims

### Claim 1

A therapeutic wound gel consisting essentially of, by weight percent, about 88-97% water, about 0.4-0.6% carbomer, about 1.2-7.8% propylene glycol, about 0.6-1.3% glycerin, about 0.5% DMDM Hydantoin, about 0-0.95% citric acid, about 0.1% chondroitin sulfate and animal protein, and about 0-0.75% triethanolamine.

### Claim 2 (depends on 1)

The therapeutic would gel of claim 1 wherein the gel comprises about 0.5-0.95% citric acid and about 0.3-0.75% triethanolamine.

### Claim 3 (depends on 1)

The therapeutic would gel of claim 1 wherein the gel is formed from three compositions which are combined together, the first composition consisting essentially of about 88-99% of the water of the gel, the carbomer, the propylene glycol, and the glycerin; the second composition consisting essentially of the remaining water, the DMDM Hydantoin, and 0-0.95% citric acid; and the third composition consisting essentially of the chondroitin sulfate and animal protein and triethanolamine.
